Molecular Resistance Fingerprint of Pemetrexed and Platinum in a Long-Term Survivor of Mesothelioma

• Oluf Dimitri Røe ,

  * E-mail: oluf.roe@ntnu.no

  Affiliations Department of Cancer Research and Molecular Medicine (IKM), Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway, Cancer Clinic, Levanger Hospital, Nord-Trøndelag Health Trust, Levanger, Norway

  ⨯
• Adam Szulkin,

  Affiliation Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet and University Hospital Huddinge, Stockholm, Sweden

  ⨯
• Endre Anderssen,

  Affiliation Laboratory of Molecular Medical Research, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway

  ⨯
• Arnar Flatberg,

  Affiliation Department of Cancer Research and Molecular Medicine (IKM), Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway

  ⨯
• Helmut Sandeck,

  Affiliation Department of Pathology and Medical Genetics, St. Olavs Hospital, Trondheim, Norway

  ⨯
• Tore Amundsen,

  Affiliations Department of Thoracic Medicine, St. Olavs Hospital, Trondheim, Norway, Department of Circulation and Medical Imaging, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway

  ⨯
• Sten Even Erlandsen,

  Affiliation Department of Cancer Research and Molecular Medicine (IKM), Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway

  ⨯
• Katalin Dobra,

  Affiliation Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet and University Hospital Huddinge, Stockholm, Sweden

  ⨯
• Stein Harald Sundstrøm

  Affiliation Cancer Clinic, Levanger Hospital, Nord-Trøndelag Health Trust, Levanger, Norway

  ⨯